CLASSIFICATION
GHRH Analogue
ACNE
None
WATER RETENTION
None
HBR
None
HEPATOTOXICITY
None
AROMATIZATION
None
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
SUBSTANCE
GHRH Peptide
Introducing CJC-1295, a powerful synthetic analogue of growth hormone-releasing hormone (GHRH) consisting of 30 amino acids. Research shows that this peptide dramatically boosts the secretion of growth hormone (GH) and IGF-1 while maintaining the natural pulsatile release of GH, ensuring your body's processes remain in harmony.
Often combined with Ipamorelin, CJC-1295 enhances specificity as a GHRH, offering similar benefits in growth hormone secretion without triggering appetite or increasing cortisol, acetylcholine, prolactin, or aldosterone?common issues with other peptides. Users frequently report high tolerability, making it a superb companion to Ipamorelin.
Target Gland: Pituitary
- Elevates growth hormone and IGF-1 levels without raising prolactin
- Promotes increased lean mass and body weight through enhanced protein synthesis
- Aids in muscle development
- Boosts bone density
- Supports immune functionality
- Improves cognitive performance and memory
- Stimulates collagen production
- Assists in fat loss
- Facilitates cellular repair and regeneration
Advantages of CJC-1295:
Moreover, CJC-1295 is known to promote deep, restorative slow-wave sleep, essential for optimizing muscle growth, memory retention, and overall rejuvenation.
GHRH is naturally synthesized in the hypothalamus and plays a vital role in stimulating the pituitary gland to release GH in a pulsatile manner. However, GHRH has a short half-life of just a few minutes, which results in rapid elimination and fleeting effects.
Types of CJC-1295:
The active segment of GHRH consists of the first 29 amino acids and is commercially available as Sermorelin. This was further refined to extend its half-life to 30 minutes, giving rise to CJC-1295. The addition of a Drug Affinity Complex (DAC) to CJC-1295 enhances its duration, extending its half-life to approximately 8 days?known as CJC-1295 + DAC. A non-DAC version is also available, mimicking the natural GH spikes that occur nightly.
With the extended half-life from DAC, injections can be administered only once or twice a week. However, this prolonged presence in the bloodstream can lead to a consistent stimulation of GH release via the GHRH receptor, which may not accurately reflect natural physiological patterns and could lessen the amplitude of GH pulses, potentially impacting GH-responsive tissues.
When using long-acting CJC molecules, it is recommended to take "hormone holidays" every three to six months, lasting three months each, to allow the pituitary gland time to recover. During these breaks, Sermorelin is suggested as a suitable alternative to CJC-1295 + DAC.
Safety Considerations:
These 'hormone holidays' may also help mitigate the risk of developing GH resistance, which could occur due to neutralizing antibodies or reduced GH receptor availability in tissues (down-regulation). While these concerns are theoretical, extensive long-term studies are still needed to address them.
Possible side effects of CJC-1295 include local reactions at the injection site (such as irritation, redness, swelling, pain, and itching), headaches, diarrhea, vasodilation (flushing, warmth, and transient low blood pressure), nausea, and abdominal discomfort.